Femasys Inc. (NASDAQ:FEMY) Short Interest Update

Femasys Inc. (NASDAQ:FEMY) was the recipient of a large decrease in short interest during the month of June. As of June 15th, there was short interest totaling 198,600 shares, a decrease of 94.0% from the May 31st total of 3,326,404 shares. Based on an average trading volume of 78,232 shares, the days-to-cover ratio is presently 2.5 days. Approximately 7.1% of the company’s shares are sold short.

Hedge Funds Weigh In On Femasys

Institutional investors and hedge funds have recently made changes to their positions in the stock. Kovack Advisors Inc. purchased a new stake in shares of Femasys during the fourth quarter worth approximately $27,000. HRT Financial LP purchased a new position in Femasys in the fourth quarter valued at $30,000. Cetera Investment Advisers purchased a new position in Femasys in the fourth quarter valued at $36,000. Osaic Holdings Inc. acquired a new stake in Femasys in the second quarter valued at $45,000. Finally, State Street Corp lifted its holdings in Femasys by 43.5% during the 4th quarter. State Street Corp now owns 80,869 shares of the company’s stock worth $47,000 after buying an additional 24,500 shares during the last quarter. 65.27% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently weighed in on FEMY shares. Lake Street Capital started coverage on shares of Femasys in a report on Tuesday, March 3rd. They issued a “buy” rating and a $30.00 target price for the company. Weiss Ratings raised Femasys from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, June 3rd. Finally, Wall Street Zen upgraded Femasys to a “hold” rating in a report on Saturday, June 13th. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $106.67.

Femasys Stock Down 1.9%

Shares of Femasys stock traded down $0.07 during trading hours on Thursday, reaching $3.60. 48,838 shares of the company were exchanged, compared to its average volume of 64,095. Femasys has a 1 year low of $3.50 and a 1 year high of $22.20. The stock’s fifty day moving average is $6.83 and its 200 day moving average is $9.97. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.98 and a current ratio of 3.91. The firm has a market cap of $10.87 million, a PE ratio of -0.67 and a beta of -2.23.

Femasys (NASDAQ:FEMY) last released its earnings results on Friday, May 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.33) by $1.43. Femasys had a negative return on equity of 258.08% and a negative net margin of 521.97%.The firm had revenue of $0.42 million during the quarter, compared to analyst estimates of $0.77 million.

Femasys Company Profile

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.